Brief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
16/03/2026 21:00
March 16 (Reuters) - Innocan Pharma Corp IP40.F: INNOCAN PHARMA CORP - TO OFFER UP TO 3.75 MILLION UNITS IN IPO - SEC FILING INNOCAN PHARMA CORP - ANTICIPATED US IPO PRICE BETWEEN $5.00 AND $6.00 PER UNIT - SEC FILING INNOCAN PHARMA CORP - APPLIED TO LIST COMMON SHARES ON NYSE AMERICAN, UNDER THE SYMBOLS “INNP” INNOCAN PHARMA CORP: THINKEQUITY IS UNDERWRITER TO US IPO Further company coverage: IP40.F ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Innocan Pharma
See all newsBrief: Innocan Pharma Corp To Offer Up To 3.75 Million Units In IPO - SEC Filing
Brief: Innocan Pharma Announces Promising Results Of LPT-CBD Administered To Gottingen Minipigs
Brief: Innocan Pharma Corp - Liposomal Cbd Injection Technology Patent Allowed In Japan
Brief: Innocan Pharma Corp Now Sees U.S IPO Of 1.1 Million Units - SEC Filing
Brief: Innocan Pharma Announces Details Of Proposed Share Consolidation